Medical Web Times * Bite Size Medical News for Medical Professionals in the know
Bite Size Medical News Monday January 5, 2009 Read the latest medical news now

FDA Approves New Drug to Treat Severe Form of Epilepsy

November 20, 2008, 5:50 am by FDA US Food & Drug Administration

The U.S. Food and Drug Administration has approved a new drug, Banzel (rufinamide), for use as an adjunctive (add-on) treatment for seizures associated with Lennox-Gastaut syndrome.

Read the full article


More from FDA US Food & Drug Administration

FDA Prevents Two Dairies from Adulterating Animal Drugs and Food
FDA US Food & Drug Administration: January 2, 2009, 9:22 am
The U.S. Food and Drug Administration announced today that the District Court for the District of New Mexico has enjoined Do-Rene and Clover Knolls Dairies and their owners, Douglas B. Handley and

FDA Announces Class I Recall of Ophthalmic Surgical Device
FDA US Food & Drug Administration: January 2, 2009, 9:22 am
The U.S. Food and Drug Administration announced a Class I recall of lot no. UD30654 of Healon D, an ophthalmic viscosurgical device (OVD) manufactured by Advanced Medical Optics Inc. (AMO) of Santa

FDA Approves First Nucleic Acid Test to Screen for Additional Types of HIV in Donated Blood and Tissue
FDA US Food & Drug Administration: December 30, 2008, 5:51 am
The U.S. Food and Drug Administration today approved the cobas TaqScreen MPX Test, the first nucleic acid test that screens for the presence of two divergent types of HIV in donated blood

FDA Approves Drug for Patients with Advanced Prostate Cancer
FDA US Food & Drug Administration: December 29, 2008, 10:32 am
The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. Degarelix is intended to treat patients with advanced prostate cancer.

FDA Approves First Imaging Agent to Enhance Scans of Blood Flow
FDA US Food & Drug Administration: December 24, 2008, 12:25 pm
The U.S. Food and Drug Administration today approved Vasovist Injection (gadofosveset trisodium), the first contrast imaging agent for use in patients undergoing magnetic resonance angiography, or MRA, a minimally invasive test for


Medical Web Times * Bite Size Medical News | Disclaimer | Medical Web Marketing by Vital Element, Inc.